Navigation Links
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
Date:7/17/2009

SAN MATEO, Calif., July 17 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX) announced today that Bruce A. Peacock has resigned from his roles as Audit Committee chairman and director to focus on his responsibilities as CEO of privately-held Alba Therapeutics.

Mr. Peacock commented, "While there is no opportune time to resign, I feel confident that NeurogesX is well positioned following the recent E.U. approval of Qutenza(TM) and the partnership with Astellas Pharma Europe Ltd. to commercialize Qutenza in Europe, and for the ongoing NDA review in the United States. In the wake of these accomplishments I am comfortable leaving NeurogesX while I focus more of my energies on Alba Therapeutics."

Tony DiTonno, NeurogesX CEO commented, "We would like to thank Bruce for all his contributions to NeurogesX during the initial regulatory approval and E.U. partnership discussions surrounding Qutenza. We are disappointed in his resignation but certainly understand the rationale and wish him well in his future endeavors."

Following Mr. Peacock's departure NeurogesX has received a Nasdaq Staff Deficiency Letter dated July 14, 2009 indicating that the company fails to comply with Nasdaq's audit committee composition requirements for continued listing as set forth in Listing Rule 5605(c)(2)(A), which requires that the company's Audit Committee be comprised of at least three members, each of whom are independent.

Consistent with Listing Rule 5605(c)(4)(B) the company has until the earlier of its next annual shareholders' meeting or June 29, 2010 to name a third director as a member of the Audit Committee so that the company regains compliance with the requirements of Listing Rule 5605(c)(2)(A).

An active search for Mr. Peacoc
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
2. NeurogesX Reports Fourth Quarter and Year-End 2008 Results
3. NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
4. NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
5. NeurogesX to Present at Susquehanna Financial Groups 2nd Annual SIGnificant Options in Healthcare Conference
6. NeurogesX to Present at RBC Capital Markets 2007 Healthcare Conference
7. NeurogesX to Report Third Quarter 2007 Financial Results on November 14, 2007
8. SXC Health Solutions announces contract with largest workers compensation organization in the U.S.
9. Masimo Announces Settlement of Lawsuit
10. NHP Announces Second Quarter Earnings Release Date and Webcast/Conference Call
11. JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Many Americans are diagnosed ... diabetes type 2 at bay, patients should consider this ... the necessary lifestyle changes. While some diabetes risk factors ... advanced age, or belonging to certain ethnic groups, there ... their weight. Carrying extra pounds, especially in the abdomen, ...
(Date:8/29/2014)... Scientists from four European countries say ... correlates with overall survival of mesothelioma. Surviving Mesothelioma has ... Click here to read it now. , Doctors ... cases of 523 mesothelioma patients who were ... [progression-free survival at 18 weeks after treatment] was strongly ...
(Date:8/29/2014)... 2014 Hep-Lock IV lines are often ... difficult to keep in place comfortably. "I saw a ... discomfort caused by medical tape," said an inventor from ... secure hep-lock IV lines." , The patent-pending IV Ease ... which avoids irritated skin and allergic reactions. It also ...
(Date:8/29/2014)... 29, 2014 A sensor measures ... data, which are used by various industries. Mobile ... and fitness devices to measure various body parameters. ... assist in regular patient monitoring. This would help ... treatment results. Sensors help in gathering patient health-related ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 In 2014, ... physicians retiring, merging or selling their practices. The Deloitte’s ... are likely to retire earlier than planned in the ... most U.S physicians are concerned about the future of ... market. In general, physicians are cynical and worried about ...
Breaking Medicine News(10 mins):Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 3Health News:European Study Says Disease Progression Predicts Mesothelioma Survival Better Than Treatment Response, According to Surviving Mesothelioma 2Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 2Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 3Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 4Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 5Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 2Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 3Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 4
... Ill., March 11 Citing concerns,about the spread ... and,ecological damage, Dr. Gail Golab, PhD, DVM, director ... Division, spoke on the,dangers of nonhuman primates kept ... of Representatives Committee on Natural Resources., The ...
... rates, but one expert urges caution , , TUESDAY, ... specialized hospitals improved survival time for ovarian cancer patients, ... researchers examined data on 8,621 ovarian cancer patients treated ... women, 40 percent were treated in general hospitals, 41 ...
... Swiss study found standard infection control was just ... News) -- Universal screening for a common antibiotic-resistant ... at reducing the rate of hospital-acquired infections in ... bacteria, methicillin-resistant Staphylococcus aureus (MRSA), is ...
... Greatest burden falls on African-American adolescents, CDC researchers find, ... 3 million teenaged girls have at least one sexually ... The most severely affected are African-American teens. In fact, ... compared with 20 percent of white teenaged girls. , ...
... nurses,and other healthcare workers in Ohio saw their dreams ... Association flooded the state,with hostile organizers and bombarded workers ... them to vote against the union., In the ... of the,AFL-CIO, the workers have for now called off ...
... Current recommendations for weight gain during pregnancy developed ... should be revised, according to an internationally recognized obesity ... and womens health at Saint Louis University. , The ... research on obesity during pregnancy, appears in the March ...
Cached Medicine News:Health News:AVMA Urges Outlawing Trafficking of Chimps, Monkeys and Nonhuman Primates and Pets 2Health News:Specialized Care for Ovarian Cancer Improves Outcomes 2Health News:Universal Screening for MRSA in Hospitals Made Little Difference 2Health News:Universal Screening for MRSA in Hospitals Made Little Difference 3Health News:One in 4 Teen Girls Has a Sexually Transmitted Disease 2Health News:One in 4 Teen Girls Has a Sexually Transmitted Disease 3Health News:SEIU: Thousands of Ohio Nurses and Other Healthcare Employees Denied a Voice at Work After Vicious Union-Busting Campaign by the California Nurses Association 2Health News:Revise guidelines for weight gain during pregnancy, says Saint Louis U. obstetrician 2
(Date:8/28/2014)... Mass. , Aug. 28, 2014  Decision ... system market will grow strongly through 2022 at ... percent. This will be largely supported by strong ... will increase demand for imaging procedures. The Indian ... allow more facilities to purchase or upgrade diagnostic ...
(Date:8/28/2014)... /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Landscape Poland " an essential source of information ... market and provides insights into the demographic, regulatory, ... report provides valuable insights into the trends and ...
(Date:8/28/2014)... Japan , Aug. 28, 2014 ... of the post-marketing commitment and submissions of data ... including the United States ... Medicines Agency (EMA) and the Japanese Ministry of ... Pharmaceuticals and Medical Devices Agency (PMDA) for pioglitazone ...
Breaking Medicine Technology:Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6
... a spectro-fluorometer supplied by HORIBA ... a new type of spectro-fluorometer ... various components. The flexible system ... choose components that best suit ...
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The new Gemini EM microplate spectrofluorometer builds on the successful Gemini platform. This next generation reader incorporates all of the high performance features of the Gemini XS with new capab...
Inquire...
Medicine Products: